Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
I tried a macho, creatine-loaded cereal “for men.” Did I mention I'm a woman? - 25 Pizza Fixings That Characterize Your Character
- 36 Exceptionally Appraised Summer Travel Objections
- 4Experience Is standing by: History's Most noteworthy Travelers
- 510 Demonstrated Tips to Boost Your New Android Cell phone: A Thorough Aide
- 10 Famous Frozen yogurt Flavors All over The Planet
- The Most Vital Crossroads in Olympic History
- Manual for extravagance SUVs for seniors
- A definitive Manual for 2024's Most In vogue Wedding Dresses
- Astonishing Deserts All over The Planet You Really want To Visit
- Find the Insider facts of Viable Advertising: Building a Positive Brand Picture
- UN rights chief says Israeli policy in West Bank 'resembles apartheid system'
- Unfathomable and Entertaining Legal disputes That Surprise everyone
- Instructions to Upgrade the Proficiency of Your Sunlight powered chargers
